Terms: = Brain cancer AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148 AND Prognosis
5 results:
1. Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3-mediated cancer development.
Seo EB; Jang HJ; Kwon SH; Kwon YJ; Kim SK; Lee SH; Jeong AJ; Shin HM; Kim YN; Ma S; Kim H; Lee YH; Suh PG; Ye SK
Hepatol Commun; 2022 Nov; 6(11):3234-3246. PubMed ID: 36153805
[TBL] [Abstract] [Full Text] [Related]
2. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
[TBL] [Abstract] [Full Text] [Related]
3. Phospholipase Cγ1 (plcg1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients.
Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z
Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421
[TBL] [Abstract] [Full Text] [Related]
4. Phospholipase Cγ1 represses colorectal cancer growth by inhibiting the Wnt/β-catenin signaling axis.
Shin KJ; Jang HJ; Lee YJ; Lee YG; Suh PG; Yang YR; Chae YC
Biochem Biophys Res Commun; 2021 Nov; 577():103-109. PubMed ID: 34509721
[TBL] [Abstract] [Full Text] [Related]
5. [Expression of nm23 and proliferating cell nuclear antigen (PCNA) in human brain gliomas and their significance].
Tan PG; Li ZQ; Cai WQ; Lu JP; Xie FS; Weng Y
Ai Zheng; 2003 Oct; 22(10):1077-80. PubMed ID: 14558955
[TBL] [Abstract] [Full Text] [Related]
